Technical Analysis for TRDA - Entrada Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 14.32 | 0.49% | 0.07 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 200 DMA Resistance | Bearish | 0.49% | |
| 50 DMA Resistance | Bearish | 0.49% | |
| Golden Cross | Bullish | 0.49% | |
| Pocket Pivot | Bullish Swing Setup | 0.49% | |
| Volume Surge | Other | 0.49% | |
| Oversold Stochastic | Weakness | 0.49% |
| Alert | Time |
|---|---|
| Down 2 % | about 6 hours ago |
| Fell Below Previous Day's Low | about 8 hours ago |
| 60 Minute Opening Range Breakdown | about 8 hours ago |
| 10 DMA Resistance | about 9 hours ago |
| 200 DMA Resistance | about 10 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 08/06/2024
Entrada Therapeutics, Inc. Description
Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles (EEV™), to engage intracellular targets that have long been considered inaccessible and undruggable. The Company’s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV Platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular disease, immunology, oncology and diseases of the central nervous system. The Company’s lead oligonucleotide programs include ENTR-601-44 targeting Duchenne muscular dystrophy (DMD), and a follow-on program targeting myotonic dystrophy type 1 (DM1).
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Neuromuscular Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.44 |
| 52 Week Low | 10.915 |
| Average Volume | 90,180 |
| 200-Day Moving Average | 14.43 |
| 50-Day Moving Average | 14.51 |
| 20-Day Moving Average | 15.17 |
| 10-Day Moving Average | 14.51 |
| Average True Range | 0.72 |
| RSI (14) | 44.75 |
| ADX | 23.15 |
| +DI | 16.81 |
| -DI | 14.87 |
| Chandelier Exit (Long, 3 ATRs) | 14.31 |
| Chandelier Exit (Short, 3 ATRs) | 16.12 |
| Upper Bollinger Bands | 16.64 |
| Lower Bollinger Band | 13.69 |
| Percent B (%b) | 0.21 |
| BandWidth | 19.43 |
| MACD Line | -0.18 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.1895 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.15 | ||||
| Resistance 3 (R3) | 15.11 | 14.81 | 15.01 | ||
| Resistance 2 (R2) | 14.81 | 14.60 | 14.82 | 14.96 | |
| Resistance 1 (R1) | 14.56 | 14.47 | 14.41 | 14.60 | 14.92 |
| Pivot Point | 14.26 | 14.26 | 14.18 | 14.27 | 14.26 |
| Support 1 (S1) | 14.01 | 14.05 | 13.86 | 14.05 | 13.72 |
| Support 2 (S2) | 13.71 | 13.92 | 13.72 | 13.68 | |
| Support 3 (S3) | 13.46 | 13.71 | 13.63 | ||
| Support 4 (S4) | 13.50 |
